Status:
COMPLETED
Effect of Acupressure in Migraine: Single-blinded, Randomized, Controlled Clinical Trial
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
China Medical University, Taiwan
Conditions:
Migraine; Status
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
Background : Migraine is one of the most complex, prevalent, debilitating neurologic disorder in the world. In clinical experience, there are limitation over western medicine for migraine, especially...
Detailed Description
Introduction: Migraine is one of the most complex, prevalent, debilitating neurologic disorder and the prevalence higher in female group. In general, there are many kinds of therapy for migraine nowa...
Eligibility Criteria
Inclusion
- A. Inclusion criteria
- Age ranged from 20 to 50-year-old (inclusion)
- Female or male.
- Neurological examination was within normal limit.
- Neither epileptiform discharge from EEG nor abnormality of neuroimage
- B. Exclusion criteria
- Headache was results from adverse effects for NSAIDs and Propranolol.
- Active skin lesion or oozing wound over PC6 acupoints.
- Pregnancy or lactation.
- Recent traumatic brain injury or brain tumor.
- Secondary headache
- Brain surgical history.
- Refuse sign informed consent.
- Extremely abnormal metabolic disturbance (such as iron deficiency anemia, hypo/hypernatremia, hypo/hyperkalemia, hypo/hypercalcemia, hypo/ hypermagnesemia) and liver/renal dysfunction ALT \> 3x normal upper limits; creatinine \>1.4)
Exclusion
Key Trial Info
Start Date :
July 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2021
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04429048
Start Date
July 4 2020
End Date
July 8 2021
Last Update
July 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Yunlin Branch
Douliu, Yunlin County, Taiwan, 64041